The primary objective is to evaluate if repetitive transcranial magnetic stimulation (rTMS)
with theta burst frequency over dorsomedial prefrontal cortex (DMPFC) is an effective
treatment for negative symptoms (anhedonia and avolition) in schizophrenia or depression.
Other objectives are to increase the understanding of the underlying neurobiology of negative
symptoms and the mechanisms for the treatment effect of rTMS.